Floatz logo

12 assets in Leukemia, Myeloid, Accelerated-Phase

Therapeutic assets addressing Leukemia, Myeloid, Accelerated-Phase, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Fludarabine
Leukemia, Myeloid, Accelerated-Phase
University of Illinois at ChicagoP2BBB (73)
Cyclophosphamide
Leukemia, Myeloid, Accelerated-Phase
University of Illinois at ChicagoP2BBB (72)
Cyclosporin A
Leukemia, Myeloid, Accelerated-Phase
University of Michigan Rogel Cancer CenterP2BBB (72)
Tacrolimus
Leukemia, Myeloid, Accelerated-Phase
University of Michigan Rogel Cancer CenterP2BB (69)
Methotrexate
Leukemia, Myeloid, Accelerated-Phase
University of Michigan Rogel Cancer CenterP2BB (66)
Busulfanum
Leukemia, Myeloid, Accelerated-Phase
University of Illinois at ChicagoP2BB (64)
Vorinostat
Leukemia, Myeloid, Accelerated-Phase
University of Michigan Rogel Cancer CenterP2B (62)
Orca-Q
Leukemia, Myeloid, Accelerated-Phase
University of FloridaP1/2CCC (48)
Ponatinib
Leukemia, Myeloid, Accelerated-Phase
Incyte Biosciences International SàrlP1/2CCC (48)